+1 347 708 0418
The Monoclonal Antibody Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Monoclonal Antibody Service size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Monoclonal Antibody Service market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Monoclonal Antibody Service market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Reagents
Drugs
Other
Market segment by Application, can be divided into
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Market segment by players, this report covers
Pfizer
Roche
Eli Lilly
Bayer
Amgen
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Merck
Abbott Laboratories
GSK
BMS
Alexion
UCB
Seattle Genetics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Monoclonal Antibody Service product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Monoclonal Antibody Service, with revenue, gross margin and global market share of Monoclonal Antibody Service from 2019 to 2021.
Chapter 3, the Monoclonal Antibody Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Monoclonal Antibody Service market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Monoclonal Antibody Service research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Monoclonal Antibody Service
1.2 Classification of Monoclonal Antibody Service by Type
1.2.1 Overview: Global Monoclonal Antibody Service Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Monoclonal Antibody Service Revenue Market Share by Type in 2020
1.2.3 Reagents
1.2.4 Drugs
1.2.5 Other
1.3 Global Monoclonal Antibody Service Market by Application
1.3.1 Overview: Global Monoclonal Antibody Service Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diagnostic Laboratories
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.4 Global Monoclonal Antibody Service Market Size & Forecast
1.5 Global Monoclonal Antibody Service Market Size and Forecast by Region
1.5.1 Global Monoclonal Antibody Service Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Monoclonal Antibody Service Market Size by Region, (2016-2021)
1.5.3 North America Monoclonal Antibody Service Market Size and Prospect (2016-2026)
1.5.4 Europe Monoclonal Antibody Service Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Monoclonal Antibody Service Market Size and Prospect (2016-2026)
1.5.6 South America Monoclonal Antibody Service Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Monoclonal Antibody Service Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Monoclonal Antibody Service Market Drivers
1.6.2 Monoclonal Antibody Service Market Restraints
1.6.3 Monoclonal Antibody Service Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Monoclonal Antibody Service Product and Solutions
2.1.4 Pfizer Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Monoclonal Antibody Service Product and Solutions
2.2.4 Roche Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Recent Developments and Future Plans
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Monoclonal Antibody Service Product and Solutions
2.3.4 Eli Lilly Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Monoclonal Antibody Service Product and Solutions
2.4.4 Bayer Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bayer Recent Developments and Future Plans
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Monoclonal Antibody Service Product and Solutions
2.5.4 Amgen Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Amgen Recent Developments and Future Plans
2.6 Sanofi-Aventis
2.6.1 Sanofi-Aventis Details
2.6.2 Sanofi-Aventis Major Business
2.6.3 Sanofi-Aventis Monoclonal Antibody Service Product and Solutions
2.6.4 Sanofi-Aventis Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sanofi-Aventis Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Monoclonal Antibody Service Product and Solutions
2.7.4 Johnson & Johnson Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 Novo Nordisk
2.8.1 Novo Nordisk Details
2.8.2 Novo Nordisk Major Business
2.8.3 Novo Nordisk Monoclonal Antibody Service Product and Solutions
2.8.4 Novo Nordisk Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Novo Nordisk Recent Developments and Future Plans
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Monoclonal Antibody Service Product and Solutions
2.9.4 Merck Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Merck Recent Developments and Future Plans
2.10 Abbott Laboratories
2.10.1 Abbott Laboratories Details
2.10.2 Abbott Laboratories Major Business
2.10.3 Abbott Laboratories Monoclonal Antibody Service Product and Solutions
2.10.4 Abbott Laboratories Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Abbott Laboratories Recent Developments and Future Plans
2.11 GSK
2.11.1 GSK Details
2.11.2 GSK Major Business
2.11.3 GSK Monoclonal Antibody Service Product and Solutions
2.11.4 GSK Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 GSK Recent Developments and Future Plans
2.12 BMS
2.12.1 BMS Details
2.12.2 BMS Major Business
2.12.3 BMS Monoclonal Antibody Service Product and Solutions
2.12.4 BMS Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 BMS Recent Developments and Future Plans
2.13 Alexion
2.13.1 Alexion Details
2.13.2 Alexion Major Business
2.13.3 Alexion Monoclonal Antibody Service Product and Solutions
2.13.4 Alexion Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Alexion Recent Developments and Future Plans
2.14 UCB
2.14.1 UCB Details
2.14.2 UCB Major Business
2.14.3 UCB Monoclonal Antibody Service Product and Solutions
2.14.4 UCB Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 UCB Recent Developments and Future Plans
2.15 Seattle Genetics
2.15.1 Seattle Genetics Details
2.15.2 Seattle Genetics Major Business
2.15.3 Seattle Genetics Monoclonal Antibody Service Product and Solutions
2.15.4 Seattle Genetics Monoclonal Antibody Service Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Seattle Genetics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Monoclonal Antibody Service Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Monoclonal Antibody Service Players Market Share
3.2.2 Top 10 Monoclonal Antibody Service Players Market Share
3.2.3 Market Competition Trend
3.3 Monoclonal Antibody Service Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Monoclonal Antibody Service Revenue and Market Share by Type (2016-2021)
4.2 Global Monoclonal Antibody Service Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Monoclonal Antibody Service Revenue Market Share by Application (2016-2021)
5.2 Monoclonal Antibody Service Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Monoclonal Antibody Service Revenue by Type (2016-2026)
6.2 North America Monoclonal Antibody Service Revenue by Application (2016-2026)
6.3 North America Monoclonal Antibody Service Market Size by Country
6.3.1 North America Monoclonal Antibody Service Revenue by Country (2016-2026)
6.3.2 United States Monoclonal Antibody Service Market Size and Forecast (2016-2026)
6.3.3 Canada Monoclonal Antibody Service Market Size and Forecast (2016-2026)
6.3.4 Mexico Monoclonal Antibody Service Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Monoclonal Antibody Service Revenue by Type (2016-2026)
7.2 Europe Monoclonal Antibody Service Revenue by Application (2016-2026)
7.3 Europe Monoclonal Antibody Service Market Size by Country
7.3.1 Europe Monoclonal Antibody Service Revenue by Country (2016-2026)
7.3.2 Germany Monoclonal Antibody Service Market Size and Forecast (2016-2026)
7.3.3 France Monoclonal Antibody Service Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Monoclonal Antibody Service Market Size and Forecast (2016-2026)
7.3.5 Russia Monoclonal Antibody Service Market Size and Forecast (2016-2026)
7.3.6 Italy Monoclonal Antibody Service Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Monoclonal Antibody Service Revenue by Type (2016-2026)
8.2 Asia-Pacific Monoclonal Antibody Service Revenue by Application (2016-2026)
8.3 Asia-Pacific Monoclonal Antibody Service Market Size by Region
8.3.1 Asia-Pacific Monoclonal Antibody Service Revenue by Region (2016-2026)
8.3.2 China Monoclonal Antibody Service Market Size and Forecast (2016-2026)
8.3.3 Japan Monoclonal Antibody Service Market Size and Forecast (2016-2026)
8.3.4 South Korea Monoclonal Antibody Service Market Size and Forecast (2016-2026)
8.3.5 India Monoclonal Antibody Service Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Monoclonal Antibody Service Market Size and Forecast (2016-2026)
8.3.7 Australia Monoclonal Antibody Service Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Monoclonal Antibody Service Revenue by Type (2016-2026)
9.2 South America Monoclonal Antibody Service Revenue by Application (2016-2026)
9.3 South America Monoclonal Antibody Service Market Size by Country
9.3.1 South America Monoclonal Antibody Service Revenue by Country (2016-2026)
9.3.2 Brazil Monoclonal Antibody Service Market Size and Forecast (2016-2026)
9.3.3 Argentina Monoclonal Antibody Service Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Monoclonal Antibody Service Revenue by Type (2016-2026)
10.2 Middle East & Africa Monoclonal Antibody Service Revenue by Application (2016-2026)
10.3 Middle East & Africa Monoclonal Antibody Service Market Size by Country
10.3.1 Middle East & Africa Monoclonal Antibody Service Revenue by Country (2016-2026)
10.3.2 Turkey Monoclonal Antibody Service Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Monoclonal Antibody Service Market Size and Forecast (2016-2026)
10.3.4 UAE Monoclonal Antibody Service Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Monoclonal Antibody Service Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Monoclonal Antibody Service Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Monoclonal Antibody Service Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Monoclonal Antibody Service Revenue (USD Million) by Region (2016-2021)
Table 5. Global Monoclonal Antibody Service Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Monoclonal Antibody Service Product and Solutions
Table 9. Pfizer Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Monoclonal Antibody Service Product and Solutions
Table 13. Roche Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 15. Eli Lilly Major Business
Table 16. Eli Lilly Monoclonal Antibody Service Product and Solutions
Table 17. Eli Lilly Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bayer Corporate Information, Head Office, and Major Competitors
Table 19. Bayer Major Business
Table 20. Bayer Monoclonal Antibody Service Product and Solutions
Table 21. Bayer Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Amgen Corporate Information, Head Office, and Major Competitors
Table 23. Amgen Major Business
Table 24. Amgen Monoclonal Antibody Service Product and Solutions
Table 25. Amgen Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors
Table 27. Sanofi-Aventis Major Business
Table 28. Sanofi-Aventis Monoclonal Antibody Service Product and Solutions
Table 29. Sanofi-Aventis Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Monoclonal Antibody Service Product and Solutions
Table 33. Johnson & Johnson Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 35. Novo Nordisk Major Business
Table 36. Novo Nordisk Monoclonal Antibody Service Product and Solutions
Table 37. Novo Nordisk Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Merck Corporate Information, Head Office, and Major Competitors
Table 39. Merck Major Business
Table 40. Merck Monoclonal Antibody Service Product and Solutions
Table 41. Merck Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 43. Abbott Laboratories Major Business
Table 44. Abbott Laboratories Monoclonal Antibody Service Product and Solutions
Table 45. Abbott Laboratories Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. GSK Corporate Information, Head Office, and Major Competitors
Table 47. GSK Major Business
Table 48. GSK Monoclonal Antibody Service Product and Solutions
Table 49. GSK Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. BMS Corporate Information, Head Office, and Major Competitors
Table 51. BMS Major Business
Table 52. BMS Monoclonal Antibody Service Product and Solutions
Table 53. BMS Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Alexion Corporate Information, Head Office, and Major Competitors
Table 55. Alexion Major Business
Table 56. Alexion Monoclonal Antibody Service Product and Solutions
Table 57. Alexion Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. UCB Corporate Information, Head Office, and Major Competitors
Table 59. UCB Major Business
Table 60. UCB Monoclonal Antibody Service Product and Solutions
Table 61. UCB Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Seattle Genetics Corporate Information, Head Office, and Major Competitors
Table 63. Seattle Genetics Major Business
Table 64. Seattle Genetics Monoclonal Antibody Service Product and Solutions
Table 65. Seattle Genetics Monoclonal Antibody Service Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Monoclonal Antibody Service Revenue (USD Million) by Players (2019-2021)
Table 67. Global Monoclonal Antibody Service Revenue Share by Players (2019-2021)
Table 68. Breakdown of Monoclonal Antibody Service by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Monoclonal Antibody Service Players Head Office, Products and Services Provided
Table 70. Monoclonal Antibody Service Mergers & Acquisitions in the Past Five Years
Table 71. Monoclonal Antibody Service New Entrants and Expansion Plans
Table 72. Global Monoclonal Antibody Service Revenue (USD Million) by Type (2016-2021)
Table 73. Global Monoclonal Antibody Service Revenue Share by Type (2016-2021)
Table 74. Global Monoclonal Antibody Service Revenue Forecast by Type (2021-2026)
Table 75. Global Monoclonal Antibody Service Revenue by Application (2016-2021)
Table 76. Global Monoclonal Antibody Service Revenue Forecast by Application (2021-2026)
Table 77. North America Monoclonal Antibody Service Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Monoclonal Antibody Service Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Monoclonal Antibody Service Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Monoclonal Antibody Service Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Monoclonal Antibody Service Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Monoclonal Antibody Service Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Monoclonal Antibody Service Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Monoclonal Antibody Service Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Monoclonal Antibody Service Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Monoclonal Antibody Service Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Monoclonal Antibody Service Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Monoclonal Antibody Service Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Monoclonal Antibody Service Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Monoclonal Antibody Service Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Monoclonal Antibody Service Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Monoclonal Antibody Service Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Monoclonal Antibody Service Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Monoclonal Antibody Service Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Monoclonal Antibody Service Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Monoclonal Antibody Service Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Monoclonal Antibody Service Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Monoclonal Antibody Service Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Monoclonal Antibody Service Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Monoclonal Antibody Service Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Monoclonal Antibody Service Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Monoclonal Antibody Service Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Monoclonal Antibody Service Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Monoclonal Antibody Service Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Monoclonal Antibody Service Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Monoclonal Antibody Service Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Monoclonal Antibody Service Picture
Figure 2. Global Monoclonal Antibody Service Revenue Market Share by Type in 2020
Figure 3. Reagents
Figure 4. Drugs
Figure 5. Other
Figure 6. Monoclonal Antibody Service Revenue Market Share by Application in 2020
Figure 7. Diagnostic Laboratories Picture
Figure 8. Research & Academic Laboratories Picture
Figure 9. Pharmaceutical & Biotechnology Companies Picture
Figure 10. Global Monoclonal Antibody Service Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Monoclonal Antibody Service Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Monoclonal Antibody Service Revenue Market Share by Region (2016-2026)
Figure 13. Global Monoclonal Antibody Service Revenue Market Share by Region in 2020
Figure 14. North America Monoclonal Antibody Service Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Monoclonal Antibody Service Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Monoclonal Antibody Service Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Monoclonal Antibody Service Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Monoclonal Antibody Service Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Monoclonal Antibody Service Market Drivers
Figure 20. Monoclonal Antibody Service Market Restraints
Figure 21. Monoclonal Antibody Service Market Trends
Figure 22. Pfizer Recent Developments and Future Plans
Figure 23. Roche Recent Developments and Future Plans
Figure 24. Eli Lilly Recent Developments and Future Plans
Figure 25. Bayer Recent Developments and Future Plans
Figure 26. Amgen Recent Developments and Future Plans
Figure 27. Sanofi-Aventis Recent Developments and Future Plans
Figure 28. Johnson & Johnson Recent Developments and Future Plans
Figure 29. Novo Nordisk Recent Developments and Future Plans
Figure 30. Merck Recent Developments and Future Plans
Figure 31. Abbott Laboratories Recent Developments and Future Plans
Figure 32. GSK Recent Developments and Future Plans
Figure 33. BMS Recent Developments and Future Plans
Figure 34. Alexion Recent Developments and Future Plans
Figure 35. UCB Recent Developments and Future Plans
Figure 36. Seattle Genetics Recent Developments and Future Plans
Figure 37. Global Monoclonal Antibody Service Revenue Share by Players in 2020
Figure 38. Monoclonal Antibody Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Monoclonal Antibody Service Revenue Market Share in 2020
Figure 40. Global Top 10 Players Monoclonal Antibody Service Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Monoclonal Antibody Service Revenue Share by Type in 2020
Figure 43. Global Monoclonal Antibody Service Market Share Forecast by Type (2021-2026)
Figure 44. Global Monoclonal Antibody Service Revenue Share by Application in 2020
Figure 45. Global Monoclonal Antibody Service Market Share Forecast by Application (2021-2026)
Figure 46. North America Monoclonal Antibody Service Sales Market Share by Type (2016-2026)
Figure 47. North America Monoclonal Antibody Service Sales Market Share by Application (2016-2026)
Figure 48. North America Monoclonal Antibody Service Revenue Market Share by Country (2016-2026)
Figure 49. United States Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Monoclonal Antibody Service Sales Market Share by Type (2016-2026)
Figure 53. Europe Monoclonal Antibody Service Sales Market Share by Application (2016-2026)
Figure 54. Europe Monoclonal Antibody Service Revenue Market Share by Country (2016-2026)
Figure 55. Germany Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Monoclonal Antibody Service Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Monoclonal Antibody Service Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Monoclonal Antibody Service Revenue Market Share by Region (2016-2026)
Figure 63. China Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Monoclonal Antibody Service Sales Market Share by Type (2016-2026)
Figure 70. South America Monoclonal Antibody Service Sales Market Share by Application (2016-2026)
Figure 71. South America Monoclonal Antibody Service Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Monoclonal Antibody Service Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Monoclonal Antibody Service Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Monoclonal Antibody Service Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Monoclonal Antibody Service Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Buy
